Press Releases

Latest Updates

ANNOUNCEMENT: Sativa Wellness Group Inc. Announces Closing of Transaction with Sativa Group Plc. and Resumption of Trading on the CSE

The Company would like to sincerely thank shareholders for their patience and support during the trading halt. The Transaction was subject to requisite legislative and exchange regulatory approvals in both the United Kingdom and Canada.

Going forward, Sativa is now a true vertically-integrated European seed-to-consumer cannabidiol (“CBD”) wellness company. The Company manages the cultivation of raw materials, owns extraction, packaging and testing facilities, and has developed and marketed leading consumer brands. This complete supply chain custody model ensures that retail and wholesale customers receive pharmaceutical grade CBD products they can trust.

ANNOUNCEMENT: Sativa joins the ACI toxicology study to further it’s commitment to Novel Food compliance

As part of the Sativa Group PLC’s ongoing commitment to continually deliver the highest level of regulatory compliance and substantiate ‘CBD you can trust’, the Company has become a member of the Association for the Cannabinoid Industry (ACI) Novel Food consortium and it’s landmark toxicology study, which will augment the submission of it’s own Novel Food application dossier.

ANNOUNCEMENT: Update Regarding Re-Listing of the Common Shares of Stillcanna Inc. on the Canadian Securities Exchange

Further to the Company’s news release dated September 10, 2020, Sativa wishes to provide an update on the status of the re-listing of Stillcanna Inc. (to be renamed Sativa Wellness Group Inc.) (“Stillcanna”) common shares on the Canadian Securities Exchange (the “CSE”) and the AQSE Growth Market (the “AQSE”). The Company is currently co-ordinating with Stillcanna a date of re-listing with the CSE, and continues to work diligently to fulfil the remaining conditions of re-listing.

ANNOUNCEMENT: Conditional CSE Approval of Sativa Wellness Group Inc

The Company is pleased to announce that the Canadian Securities Exchange (“CSE”) conditionally approved the Listing Application for Sativa Wellness Group Inc. on September 7, combining the operations of Sativa Group PLC and Stillcanna Inc. As previously announced, Sativa shareholders voted 99% in favour of the merger, with Stillcanna shareholders voting 99.9% in favour, and the Court sanctioned the Scheme of Arrangement, subject to unconditional CSE approval. Unconditional approval and the resumption of trading on the CSE of Sativa Wellness Group Inc.

ANNOUNCEMENT: One Day Extension for Publication of Scheme Document

Further to the announcement made by the Company on 23 June 2020, Sativa Group Plc, the UK’s leading quoted CBD wellness and medicinal cannabis Group, announces that it and StillCanna Inc have agreed to extend the date by which the Scheme Document must be posted to Sativa Shareholders until tomorrow, 22 July 2020.

ANNOUNCEMENT: Notice of Convening Hearing

Further to the announcement made by the Company on 3 June 2020 (the “Rule 2.7 Announcement”), Sativa Group Plc, the UK’s leading quoted CBD wellness and medicinal cannabis Group, confirms that is has yesterday, 22 June, issued a Part 8 Claim Form dated 22 June 2020 in the Companies Court for an Order under Section 896 of the Companies Act 2006 to convene on 14 August 2020 at 11 a.m…


• Further to the announcements made on 22 April 2020 and 20 May 2020, the boards of directors of Stillcanna Inc. (“Stillcanna”) and Sativa Group plc (“Sativa” or the “Company”) are pleased to announce that they have reached agreement on the terms of a recommended share for share exchange offer to be made by Stillcanna for the entire issued and to be issued share capital of Sativa (the “Offer”).

ANNOUNCEMENT: Statement re Rule 2.6 Extension

In accordance with Rule 2.6(c) of the Code, at the request of the Directors of Sativa, the Panel on Takeovers & Mergers (the “Panel”) has consented to an extension of the relevant deadline, until 5:00 p.m. on 3 June 2020 to enable the parties to complete the compilation…